Hyperhomocysteinemia and venous thrombosis: A meta-analysis

Thrombosis and Haemostasis

Volumn 80, Issue 6, 1998, Pages 874-877

  Den Heijer, Martin ^a,c   Rosendaal, Frits R ^b   Blom, Henk J ^c   Gerrits, Wim B J ^a   Bos, Gerard M J ^a,d  

^a LEYENBURG HOSPITAL   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Dutch Cancer Foundation

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE; METHIONINE; VITAMIN;

ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; CASE CONTROL STUDY; CONTROLLED STUDY; DIET SUPPLEMENTATION; HUMAN; HYPERHOMOCYSTEINEMIA; META ANALYSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK; RISK FACTOR; VASCULAR DISEASE; VEIN THROMBOSIS;

EID: 0031733260     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615380     Document Type: Article

References (28)

1. du Vigneaud V, Ressler C, Rachele JR. The biological synthesis of "labile methyl groups". Science 1950; 112: 267-71.
2. Carson NAJ, Neill DW. Metabolic abnormalities detected in a survey of mentally backward individuals in Northern Ireland. Arch Dis Child 1962; 37: 505-13.
3. Gerritsen T, Vaughn JG, Weisman HA. The identification of homocysteine in the urine. Biochem Biophys Res Commun 1962; 9: 493.
4. Gerritsen T, Waisman HA. Homocystinuria, an error of metabolism of methionine. Pediatrics 1964; 33: 413-20.
5. Mudd, SH, Finkelstein JD, Irreverre F, Laster L. Homocystinuria: an enzymatic defect. Science 1964; 143: 1443-5.
6. Boushy CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease - probable benefits of increasing folic acid intakes. JAMA 1995; 274: 1049-57.
7. Mudd SH, Skovby F, Levy HL, et al. The natural history of homocystinuria due to cystathionine beta synthase deficiency. Am J Hum Genet 1985; 37: 131.
8. Bienvenu T, Ankri A, Chadefaux B, Kamoun P. Plasma homocysteine assay in the exploration of thrombosis in young subjects. Presse Med 1991; 20: 9858.
9. Brattström L, Tengborn L, Israelsson B, Hultberg B. Plasma homocysteine in venous thromboembolism. Haemostasis 1991; 21: 517.
10. Bienvenu T, Ankri A, Chadefaux, Montalescot G, Kamoun P. Elevated total plasma homocysteine, a risk factor for thrombosis, relation to coagulation and fibrinolytic parameters. Thromb Res 1993; 70: 123-9.
11. Beaumont V, Malinow MR, Sexton G, Wilson D, Lemort N, Upson B, Beaumont JL. Hyperhomocyst(e)inemia, anti-estrogen antibodies and other risk factors for thrombosis in women on oral contraceptives. Atherosclerosis 1992; 94: 147-52.
12. Falcon CR, Cattaneo M, Panzeri D, Martinelli I, Munnucci PM. High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis. Arterioscler Thromb 1994; 14: 1080-3.
13. Heijer M den, Blom HJ, Gerrits WBJ, Rosendaal FR, Haak HL, Wijermans PW, Bos GMJ. Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis? Lancet 1995; 345: 882-5.
14. Amundsen T, Ueland PM, Waage A. Plasma homocysteine levels in patients with deep venous thrombosis. Arterioscler Thromb Vasc Biol 1995; 15: 1321-3.
15. Fermo I, D'Angelo SV, Paroni R, Mazzola G, Calori G, D'Angelo A. Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease. Ann Intern Med 1995; 123: 747-53.
16. den Heijer M, Koster T, Blom HJ, Bos GMJ, Briët E, Reitsma P, Vandenbroucke JP, Rosendaal FR. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996; 334: 759-62.
17. Cattaneo M, Martinelli I, Mannucci PM. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis [letter]. N Engl J Med 1996; 335: 974-5.
18. Simioni P, Prandoni P, Burlina A, Tormene D, Sardella C, Ferrari V, Benedetti L, Girolami A. Hyperhomocysteinemia and deep-vein thrombosis. A case-control study. Thromb Haemost 1996; 76: 883-6.
19. Ridker PM, Hennekens CH, Selhub J, Miletich JP, Malinow MR, Stampfer MJ. Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and the risk of future venous thrombosembolism. Circulation 1997; 95: 1777-82.
20. Kyrle PA, Stumpflen A, Hirschl M, Bialonczyk C, Herkner K, Speiser W et al. Levels of prothrombin fragment F1+2 in patients with hyperhomocysteinemia and a history of venous thromboembolism. Thromb Haemost 1997; 78: 1327-31.
21. Rothman KJ. Modern epidemiology. Boston/Toronto 1986.
22. Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 1987; 9: 1-30.
23. Rees MM, Rodgers GM. Homocysteinemia: association of a metabolic disorder with vascular disease and thrombosis. Thromb Res 1993; 71: 337-59.
24. Ueland PM, Refsum H, Brattstrom L. Plasma Homocysteine and Cardiovascular Disease. In: Atherosclerotic Cardiovascular Disease, Hemostasis, and Endothelial Function. Francis RB, Jr., ed. New York, Basel, Hong Kong: Marcel Dekker, Inc., 1993; pp 183-236.
25. Stamler JS, Slivka A. Biochemical chemistry of thiols in the vasculature and in vascular-related disease. Nut rev 1996; 54: 1-30.
26. Homocysteine Lowering Trialists' Collaboration. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. BMJ 1998; 316: 894-8.
27. den Heijer M, Brouwer IA, Bos GMJ, Blom HJ, van der Put NMJ, Spaans AP, Rosendaal FR, Thomas CMG, Haak HL, Wijermans PW, Gerrits WBJ. Vitamin supplementation reduces blood homocysteine levels. A controlled trial in patients with venous thrombosis and healthy volunteers. Arterioscler Thromb Vase Biol 1998; 18: 356-61.
28. den Heijer M, Bos GMJ, Gerrits WBJ, Blom HJ. Will a decrease of blood homocysteine by vitamin supplementation reduce the risk for vascular disease? Fibrinolysis 1994; 8 (Suppl 2): 91-2.